These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4146270)

  • 21. The effects of ajmaline in experimental and clinical arrhythmias and their relation to some electrophysiological parameters of the heart.
    Bojorges R; Pastelin G; Sanchez-Perez S; Mendez R; Kabela E
    J Pharmacol Exp Ther; 1975 Apr; 193(1):182-93. PubMed ID: 1133763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiarrhythmic actions of 4-(2-hydroxy-3-isopropylaminopropoxy)-acetanilide (ICI 50,172) in the dog heart-lung preparation.
    Laddu AR; Somani P
    J Pharmacol Exp Ther; 1969 Nov; 170(1):79-83. PubMed ID: 4390815
    [No Abstract]   [Full Text] [Related]  

  • 23. The antiarrhythmic and cardiovascular properties of 1-dimethyl isopropylamino-3-(2-phenylphenoxy)-propan-2-ol chloride, UM-424.
    Kniffen FJ; Winokur S; Counsell RE; Lucchesi BR
    J Pharmacol Exp Ther; 1976 Feb; 196(2):420-32. PubMed ID: 3643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative blood pressure and electrocardiographic changes induced by proscillaridin and ouabain.
    Melville KI; Shister HE; Klingner B
    Can J Physiol Pharmacol; 1966 Nov; 44(6):887-92. PubMed ID: 5970231
    [No Abstract]   [Full Text] [Related]  

  • 25. [Antiarrhythmic effects of crebanine].
    Yu ZP; Mu YS; Zhao ZX; Wang FC
    Zhongguo Zhong Yao Za Zhi; 1992 Nov; 17(11):685-7, 704. PubMed ID: 1301759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of prostaglandins on experimental arrhythmias.
    Mest HJ; Mentz P; Förster W
    Pol J Pharmacol Pharm; 1974; 26(1):151-8. PubMed ID: 4838275
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacokinetics and antiarrhythmic activity of ajmaline in rats subjected to coronary artery occlusion.
    Hashimoto Y; Hori R; Okumura K; Yasuhara M
    Br J Pharmacol; 1986 May; 88(1):71-7. PubMed ID: 3708225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Anti-arrhythmic activity of 17-monochloroacetylajmaline as compared with that of 17-21-dichloroacetylajmaline. Experimental and clinical study].
    Capra C; Pretolani E
    Minerva Cardioangiol; 1973 Dec; 21(12):789-820. PubMed ID: 4780270
    [No Abstract]   [Full Text] [Related]  

  • 29. The effect of adrenergic receptor antagonists on cocaine-induced ventricular fibrillation: alpha but not beta adrenergic receptor antagonists prevent malignant arrhythmias independent of heart rate.
    Billman GE
    J Pharmacol Exp Ther; 1994 Apr; 269(1):409-16. PubMed ID: 7909562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta receptor blocking and antiarrhythmic properties of tolamolol.
    Bagwell EE; Custy J; Steen RG; Newman WH
    J Pharmacol Exp Ther; 1974 Dec; 191(3):496-505. PubMed ID: 4154378
    [No Abstract]   [Full Text] [Related]  

  • 31. [Antiarrhythmic, cardiovascular and toxic effects of 4-[3'-diethylamino-2'-hydroxypropyl]-ajmaline (Tachmalcor) in comparison with ajmaline and propranolol].
    Terhaag B; Förster W; Mest HJ; Schrör K
    Pharmazie; 1976; 31(1):39-44. PubMed ID: 1257278
    [No Abstract]   [Full Text] [Related]  

  • 32. Antiarrhythmic actions of BC 105.
    Ahmad M; Achari G
    Jpn J Pharmacol; 1969 Mar; 19(1):19-24. PubMed ID: 5306219
    [No Abstract]   [Full Text] [Related]  

  • 33. The actions of verapamil on experimental arrhythmias.
    Rodrigues-Pereira E; Viana AP
    Arzneimittelforschung; 1968 Feb; 18(2):175-9. PubMed ID: 5695375
    [No Abstract]   [Full Text] [Related]  

  • 34. [Antiarrhythmic, cardiovascular and toxic actions of N,N'-bis-[3-(2'-ethoxyphenoxy)-2-hydroxypropyl]-ethlenediamine (Falirytmin) as compared to propranolol, quinidine and ajmaline].
    Terhaag B; Förster W
    Pharmazie; 1976; 31(9):635-9. PubMed ID: 1019213
    [No Abstract]   [Full Text] [Related]  

  • 35. Relationship between heart rate and ouabain toxicity in the dog heart-lung preparation.
    Lahiri PK; Laddu AR
    Jpn Heart J; 1973 Jul; 14(4):357-65. PubMed ID: 4542950
    [No Abstract]   [Full Text] [Related]  

  • 36. [Antiarrhythmic properties of fubromegan on different models of experimental cardiac arrhythmia].
    Samvelian VM; L'vov MV
    Farmakol Toksikol; 1970; 33(3):309-13. PubMed ID: 4393833
    [No Abstract]   [Full Text] [Related]  

  • 37. [Some toxic effects of ajmaline with a report of 2 cases].
    Batalov Z; Apostolos L
    Folia Med (Plovdiv); 1968; 10(6):403-11. PubMed ID: 5006193
    [No Abstract]   [Full Text] [Related]  

  • 38. Life-threatening ventricular arrhythmias during ajmaline challenge in patients with Brugada syndrome: incidence, clinical features, and prognosis.
    Conte G; Sieira J; Sarkozy A; de Asmundis C; Di Giovanni G; Chierchia GB; Ciconte G; Levinstein M; Casado-Arroyo R; Baltogiannis G; Saenen J; Saitoh Y; Pappaert G; Brugada P
    Heart Rhythm; 2013 Dec; 10(12):1869-74. PubMed ID: 24055942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ventricular arrhythmia incidence in the rat is reduced by naloxone.
    Pugsley MK; Hayes ES; Wang WQ; Walker MJ
    Pharmacol Res; 2015 Jul; 97():64-9. PubMed ID: 25920674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Oral therapy of cardiac arrhythmia using Neo-Gilurytmal (N-n-propyl-ajmalinium-hydrogentartrate)].
    Mathey D; Bleifeld W; Effert S
    Med Klin; 1973 May; 68(18):598-601. PubMed ID: 4123381
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.